Article

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease

Department of Chemistry, University of Wisconsin, Madison, Wisconsin 53706, USA.
Molecular &amp Cellular Proteomics (Impact Factor: 7.25). 11/2010; 9(11):2424-37. DOI: 10.1074/mcp.M110.001917
Source: PubMed

ABSTRACT Because of its availability, ease of collection, and correlation with physiology and pathology, urine is an attractive source for clinical proteomics/peptidomics. However, the lack of comparable data sets from large cohorts has greatly hindered the development of clinical proteomics. Here, we report the establishment of a reproducible, high resolution method for peptidome analysis of naturally occurring human urinary peptides and proteins, ranging from 800 to 17,000 Da, using samples from 3,600 individuals analyzed by capillary electrophoresis coupled to MS. All processed data were deposited in an Structured Query Language (SQL) database. This database currently contains 5,010 relevant unique urinary peptides that serve as a pool of potential classifiers for diagnosis and monitoring of various diseases. As an example, by using this source of information, we were able to define urinary peptide biomarkers for chronic kidney diseases, allowing diagnosis of these diseases with high accuracy. Application of the chronic kidney disease-specific biomarker set to an independent test cohort in the subsequent replication phase resulted in 85.5% sensitivity and 100% specificity. These results indicate the potential usefulness of capillary electrophoresis coupled to MS for clinical applications in the analysis of naturally occurring urinary peptides.

Download full-text

Full-text

Available from: Petra Zürbig, Jul 30, 2015
1 Follower
 · 
307 Views
  • Source
    • "There have been a number of studies, especially using urine, that have developed biomarkers models for a number of different diseases using capillary electrophoresis (CE) and mass spectrometry (MS). Those investigated so far range from renal disorders [16] [17] to cardiovascular disease [18] and diabetes [19]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bovine mastitis is usually caused by either Gram positive or Gram negative bacteria, reducing the quantity and quality of milk produced. This investigation using capillary electrophoresis and mass spectroscopy, studied peptides in milk from cows with clinical mastitis in comparison to milk from healthy cows to identify biomarkers for mastitis. In addition, the milk peptidome from udders infected with Gram positive Staphylococcus aureus (S. aureus) or with Gram negative Escherichia coli (E. coli), was examined to assess differential diagnosis between the causative agent. Comparison of the peptidome between healthy (n=10) and mastitic milk (n=27) identified 154 peptides for a biomarker panel which in a model for diagnosis of mastitis showed 100% sensitivity and specificity. -casein and s1 casein provided the majority of peptides identified in this model. The peptidome comparison of milk from mastitis cases caused by S. aureus (n=8) or E. coli (n=11) revealed a biomarker panel of 47 peptides which discriminated between cause of infection with a sensitivity of 75% and a specificity of 100%. -casein fragments were the most common of the peptides in this model. Peptide biomarkers of milk could be used in the diagnosis of mastitis and can discriminate between these two bacterial causes. SIGNIFICANCE: The paper describes an innovative approach to the use gel free proteomics to identify the peptides that are present in milk during clinical mastitis, which is a major cause of loss of production to dairy farmers worldwide. The use of capillary electrophoresis, liquid chromatography and mass spectrometry has been able to identify panels of peptides which can be used for disease diagnosis and for differential diagnosis of the causative bacteria of the infections of the mammary gland. As well as contributing to our knowledge of the pathophysiology of bovine mastitis the results could be the basis of improved detection and differential diagnosis of the disease.
    Journal of proteomics 04/2013; 85. DOI:10.1016/j.jprot.2013.04.027 · 3.93 Impact Factor
  • Source
    • "The interfaces can be divided into sheathflow and sheathless designs [4]. Sheath-flow interfaces use a sheath fluid that mixes with the electrophoretic stream at the exit of the separation capillary [5] [6] [7] [8] [9] [10] [11] [12] [13] [14]. The sheath liquid helps stabilize the electrospray, provides electrical contact with the distal end of the separation capillary, and allows dilution of the separation buffer to make it more compatible with ESI detection [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We report the performance of capillary zone electrophoresis coupled with an electrokinetically pumped electrospray interface and an Orbitrap-Velos mass spectrometer for high sensitivity protein analysis. We first investigated the system for quantitation of the tryptic digest of BSA. The system produced outstanding linearity with respect to peak height, number of peptide IDs, and spectral counts across the range of 12 nM to 750 nM (60 amol to 3.5 fmol) of BSA injected. One peptide produced a detection limit of 0.3 nM (1.5 amol) injected. We also analyzed 700 pg of a tryptic digest prepared from a RAW264.7 cell lysate; ten proteins were identified in triplicate analyses after filtering the data with peptide confidence value as high. This sample size corresponds to the protein content of approximately ten eukaryotic cells.
    Proteomics 10/2012; 12(19-20):3013-9. DOI:10.1002/pmic.201200100 · 3.97 Impact Factor
  • Source
    • "This model was subsequently validated in a blinded test set of 280 samples yielding 97.8% sensitivity and 85.5% specificity. Most of the CKD biomarker peptides were found to be fragments of collagen, uromodulin fragments, and some different blood protein fragments [11]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Non-invasive detection of diseases, based on urinary proteomics, is becoming an increasingly important area of research, especially in the area of chronic kidney disease (CKD). Different platforms have been used in independent studies, mostly capillary-electrophoresis coupled ESI-MS (CE-MS), liquid chromatography coupled mass spectrometry, and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). We have compared the performance of CE-MS with MALDI-MS in detecting CKD, based on a cohort of 137 urine samples (62 cases and 75 controls). Data cross-talk between the two platforms was established for the comparison of detected biomarkers. The results demonstrate superior performance of the CE-MS approach in terms of peptide resolution and obtained disease prediction accuracy rates. However, the data also demonstrate the ability of the MALDI-MS approach to separate CKD patients from controls, at slightly reduced accuracy, but expected reduced cost and time. As a consequence, a practical approach can be foreseen where MALDI-MS is employed as an inexpensive, fast, and robust screening tool to detect probable CKD. In a second step, high resolution CE-MS could be used in those patients only that scored negative for CKD in the MALDI-MS analysis, reducing costs and time of such a program.
    Journal of proteomics 07/2012; 75(18):5888-97. DOI:10.1016/j.jprot.2012.07.024 · 3.93 Impact Factor
Show more